Clinical Lung Cancer

1

Gemcitabine and Paclitaxel Combination as Second-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Phase II Study

Claudio Dazzi, Anna Cariello, Claudia Casanova, Alberto Verlicchi, Marco Montanari, Giorgio Papiani, Eva Freier, Valentina Mazza, Carlo Milandri, Alessandro Gamboni, Maximilian Papi, Maurizio Leoni, G

Journal:

Year:

2013

Language:

english

File:

PDF, 327 KB

english, 2013

2

Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin Followed by Pemetrexed Consolidation Therapy in Japanese Patients With Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer

Seiji Niho, Kaoru Kubota, Keiji Nihei, Ikuo Sekine, Minako Sumi, Risa Sekiguchi, Jumpei Funai, Sotaro Enatsu, Yuichiro Ohe, Tomohide Tamura

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 364 KB

english, 2013

3

Identifying Barriers Associated With Enrollment of Patients With Lung Cancer into Clinical Trials

Leora Horn, Vicki L. Keedy, Norma Campbell, Gabe Garcia, Amy Hayes, Brady Spencer, David P. Carbone, Alan Sandler, David H. Johnson

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 352 KB

english, 2013

4

Gefitinib-Related Interstitial Lung Disease in Taiwanese Patients With Non–Small-Cell Lung Cancer

Shih-Chieh Chang, Cheng-Yu Chang, Shu-Ju Chang, Mei-Kang Yuan, Yi-Chun Lai, Yu-Chang Liu, Cheng-Yu Chen, Li-Chiao Kuo, Chong-Jen Yu

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 333 KB

english, 2013

5

Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board

Steven C. Kao, Janette Vardy, Mark Chatfield, Peter Corte, Nick Pavlakis, Christopher Clarke, Nico van Zandwijk, Stephen Clarke

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 396 KB

english, 2013

6

Clinical Significance of the Serum Crosslinked N-Telopeptide of Type I Collagen as a Prognostic Marker for Non–Small-Cell Lung Cancer

Motohiro Tamiya, Masashi Kobayashi, Osamu Morimura, Tomomi Yasue, Takashi Nakasuji, Morita Satomu, Okafuji Kohei, Shiroyama Takayuki, Naoko Morishita, Hidekazu Suzuki, Shinji Sasada, Norio Okamoto, To

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 277 KB

english, 2013

7

Carboplatin and Paclitaxel Plus ASA404 as First-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Multicenter Single Arm Phase II Trial (SAKK 15/08)

Martin Früh, Richard Cathomas, Marco Siano, Gregor Tscherry, Alfred Zippelius, Christoph Mamot, Andreas Erdmann, Fatima Krasniqi, Daniel Rauch, Mathew Simcock, Erika Küttel, Pierre Fustier, Miklos Ple

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 307 KB

english, 2013

8

How Best to Assess the Quality of Life in Long-Term Survivors After Surgery for NSCLC? Comparison Between Clinical Predictors and Questionnaire Scores

Silvia Sterzi, Alfredo Cesario, Giacomo Cusumano, Giuseppe Corbo, Filippo Lococo, Barbara Biasotti, Luisa Maria Lapenna, Giovanni Magrone, Valentina Dall'armi, Elisa Meacci, Venanzio Porziella, Stefan

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 355 KB

english, 2013

9

A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer

Peter M. Ellis, Quincy S. Chu, Natasha Leighl, Scott A. Laurie, Holger Fritsch, Birgit Gaschler-Markefski, Steve Gyorffy, Gerd Munzert

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 389 KB

english, 2013

10

Association Between Polymorphisms in COMT, PLCH1, and CYP17A1, and Non–Small-Cell Lung Cancer Risk in Chinese Nonsmokers

Yongjun Zhang, Shi Hua, Aiqin Zhang, Xiangming Kong, Chuming Jiang, Dehou Deng, Bao Wenlong

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 276 KB

english, 2013

11

Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation

Patricia Tai, Avi Assouline, Kurian Joseph, Larry Stitt, Edward Yu

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 298 KB

english, 2013

12

Aggressive Treatment of Primary Tumor in Patients With Non–Small-Cell Lung Cancer and Exclusively Brain Metastases

Cynthia Villarreal-Garza, Dolores de la Mata, Diego G. Zavala, Eleazar O. Macedo-Perez, Oscar Arrieta

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 330 KB

english, 2013

13

Improving Outcomes for High-Risk Patients With Early-Stage Non–Small-Cell Lung Cancer: Insights from Population-Based Data and the Role of Stereotactic Ablative Radiotherapy

David A. Palma, Suresh Senan

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 895 KB

english, 2013

14

Correction

Journal:

Clinical Lung Cancer

Year:

2013

File:

PDF, 50 KB

2013

15

Editorial Board

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 60 KB

english, 2013

16

Volume 14; Issue 1

Gemcitabine and Paclitaxel Combination as Second-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Phase II Study

Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin Followed by Pemetrexed Consolidation Therapy in Japanese Patients With Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer

Identifying Barriers Associated With Enrollment of Patients With Lung Cancer into Clinical Trials

Gefitinib-Related Interstitial Lung Disease in Taiwanese Patients With Non–Small-Cell Lung Cancer

Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board

Clinical Significance of the Serum Crosslinked N-Telopeptide of Type I Collagen as a Prognostic Marker for Non–Small-Cell Lung Cancer

Carboplatin and Paclitaxel Plus ASA404 as First-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Multicenter Single Arm Phase II Trial (SAKK 15/08)

How Best to Assess the Quality of Life in Long-Term Survivors After Surgery for NSCLC? Comparison Between Clinical Predictors and Questionnaire Scores

A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer

Association Between Polymorphisms in COMT, PLCH1, and CYP17A1, and Non–Small-Cell Lung Cancer Risk in Chinese Nonsmokers

Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation

Aggressive Treatment of Primary Tumor in Patients With Non–Small-Cell Lung Cancer and Exclusively Brain Metastases

Improving Outcomes for High-Risk Patients With Early-Stage Non–Small-Cell Lung Cancer: Insights from Population-Based Data and the Role of Stereotactic Ablative Radiotherapy

Correction

Editorial Board

Table of Contents